LHCG Stock Recent News
LHCG LATEST HEADLINES
The FTC issued a second request into the UnitedHealth Group Incorporated acquisition of LHC Group, Inc. Seeking Alpha reported on rumors among traders the deal wouldn't be challenged.
LHC Group's (LHCG) third-quarter results benefit from organic growth in hospice admissions. However, home health admissions decline organically.
LHC (LHCG) delivered earnings and revenue surprises of -22.63% and 6.44%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
LHC Group's (LHCG) latest JV is expected to expand the availability of vital healthcare services to patients in the comfort of their homes.
LHC Group (LHCG) continues to benefit from strategic deals and a broad array of services.
LHC (LHCG) delivered earnings and revenue surprises of 3.81% and 0.29%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Buying and holding a stock can pay off in multiple ways for investors.